Predictive Dispatch of Volunteer First Responders: Algorithm Development and Validation.
Michael Khalemsky, Anna Khalemsky, Stephen Lankenau...
https://pubmed.ncbi.nlm.nih.gov/38015602/Actively Recruiting
Led by Drexel University · Updated on 2026-07-20
450
Participants Needed
1
Research Sites
30 weeks
Total Duration
Researchers are evaluating the UnityPhilly app, which aims to help citizen responders prevent opioid overdoses in Philadelphia. This behavioral clinical trial focuses on how different groups of people use the app to signal overdoses and respond with naloxone, a medication that can reverse overdoses. The study includes people who use opioids non-medically, those on prescription opioids, individuals in recovery, caregivers, and concerned community members to understand app effectiveness in various settings. All participants will receive training on how to use the UnityPhilly app and respond to overdoses with naloxone. The study enrolls 450 participants over 9 months from three Philadelphia neighborhoods, who will use the app and be followed for 12 months to measure outcomes such as overdose signaling and response rates. Additionally, 3,000 resident volunteers will download and use the app over two years to assess its sustainability and community reach. Participants will be involved in training, using the app, and completing follow-up surveys about their experiences. Data collected includes app usage logs, survey responses, and interviews to evaluate how well the app helps prevent overdoses and how widely it is adopted. The study will measure the rates of overdoses signaled and reversed over two years, with ongoing assessments to understand the apps long-term impact and effectiveness.
CONDITIONS
UnityPhilly Response App for Overdose Reversal
S
Stephen Lankenau, PhD
K
Kushal Naik, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Drexel University
Lead Sponsor
University of Michigan
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | UnityPhilly App (Trial Arm) | Standard Emergency Response (Calling 911) |
|---|---|---|
| What it is | A smartphone application that alerts nearby trained community responders carrying naloxone during an opioid overdose event, allowing rapid layperson intervention before EMS arrival. | The current standard response is for bystanders to call 911 so professional emergency medical services and first responders provide naloxone and medical care on scene. |
| Primary intended use | Meant to enable rapid layperson-administered naloxone and lifesaving basics during suspected opioid overdoses outside of healthcare settings, especially in at-risk neighborhoods. | Standard-of-care response provides professional prehospital overdose intervention through EMS after a bystander call, including naloxone and transport if needed. |
| Evidence status | Supported by prospective cohort and pilot studies showing feasibility, acceptability, and successful layperson overdose reversals in real-world scenarios, but outcomes from this trial are not yet reported. | Multiple large studies and real-world experience show that activating EMS by calling 911 is the established way to access naloxone and medical care for suspected community opioid overdose. Survived overdose rates depend on response times; bystander naloxone use improves survival when possible before EMS arrival. |
| Important limitations | Effectiveness depends on having sufficient trained layperson responders nearby at the moment of overdose and on bystanders recognizing an overdose and activating the app promptly. Not all communities or overdose scenarios will have timely app-driven response. Smart device, connectivity, and user engagement are all required; there may be missed events or users who do not respond in time. Published research showed delays due to responder location and occasional non-response. | Standard EMS response may be delayed due to location and system burden; opportunities for bystander naloxone before EMS arrival depend on availability of others with naloxone and training. In high-risk communities, delays from 911 call to EMS arrival can result in greater harm or death without timely layperson action. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Michael Khalemsky, Anna Khalemsky, Stephen Lankenau...
https://pubmed.ncbi.nlm.nih.gov/38015602/Gabriela Marcu, Roy Aizen, Alexis M Roth...
https://pubmed.ncbi.nlm.nih.gov/32607487/Gabriela Marcu, David G Schwartz, Janna Ataiants...
https://pubmed.ncbi.nlm.nih.gov/33568966/David G Schwartz, Janna Ataiants, Alexis Roth...
https://pubmed.ncbi.nlm.nih.gov/32954238/Janna Ataiants, Megan K Reed, David G Schwartz...
https://pubmed.ncbi.nlm.nih.gov/33887699/Drexel University
Lead Sponsor
University of Michigan
Collaborating Sponsor